| Association of type 1 diabetes vs type 2 diabetes diagnosed during childhood and adolescence with complications during teenage years and young adulthood D Dabelea, JM Stafford, EJ Mayer-Davis, R D’Agostino, L Dolan, ... Jama 317 (8), 825-835, 2017 | 715 | 2017 |
| N-acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials AV Kshirsagar, C Poole, A Mottl, D Shoham, N Franceschini, G Tudor, ... Journal of the American Society of Nephrology 15 (3), 761-769, 2004 | 342 | 2004 |
| Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes V Papademetriou, L Lovato, M Doumas, E Nylen, A Mottl, RM Cohen, ... Kidney international 87 (3), 649-659, 2015 | 256 | 2015 |
| SGLT2 inhibition for CKD and cardiovascular disease in type 2 diabetes: report of a scientific workshop sponsored by the National Kidney Foundation KR Tuttle, FC Brosius III, MA Cavender, P Fioretto, KJ Fowler, ... Diabetes 70 (1), 1-16, 2021 | 228 | 2021 |
| Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the … J Barratt, R Lafayette, J Kristensen, A Stone, D Cattran, J Floege, V Tesar, ... Kidney international 103 (2), 391-402, 2023 | 175 | 2023 |
| Design of the COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint study (CONFIDENCE) JB Green, AK Mottl, G Bakris, HJL Heerspink, JFE Mann, JB McGill, ... Nephrology Dialysis Transplantation 38 (4), 894-903, 2023 | 125 | 2023 |
| Normoalbuminuric diabetic kidney disease in the US population AK Mottl, KS Kwon, M Mauer, EJ Mayer-Davis, SL Hogan, AV Kshirsagar Journal of Diabetes and its Complications 27 (2), 123-127, 2013 | 108 | 2013 |
| Angiotensin II type 1 receptor polymorphisms and susceptibility to hypertension: a HuGE review AK Mottl, DA Shoham, KE North Genetics in Medicine 10 (8), 560-574, 2008 | 108 | 2008 |
| CureGN study rationale, design, and methods: establishing a large prospective observational study of glomerular disease LH Mariani, AS Bomback, PA Canetta, MF Flessner, M Helmuth, ... American journal of kidney diseases 73 (2), 218-229, 2019 | 96 | 2019 |
| Systematic review of safety and efficacy of COVID-19 vaccines in patients with kidney disease DA Glenn, A Hegde, E Kotzen, EB Walter, AV Kshirsagar, R Falk, A Mottl Kidney international reports 6 (5), 1407-1410, 2021 | 80 | 2021 |
| Health-related quality of life in glomerular disease PA Canetta, JP Troost, S Mahoney, AJ Kogon, N Carlozzi, SM Bartosh, ... Kidney international 95 (5), 1209-1224, 2019 | 64 | 2019 |
| UBD modifies APOL1-induced kidney disease risk JY Zhang, M Wang, L Tian, G Genovese, P Yan, JG Wilson, R Thadhani, ... Proceedings of the National Academy of Sciences 115 (13), 3446-3451, 2018 | 60 | 2018 |
| Trends in glycemic control among youth and young adults with diabetes: the SEARCH for diabetes in youth study FS Malik, KA Sauder, S Isom, BA Reboussin, D Dabelea, JM Lawrence, ... Diabetes Care 45 (2), 285-294, 2022 | 58 | 2022 |
| Co-occurrence of early diabetes-related complications in adolescents and young adults with type 1 diabetes: an observational cohort study KA Sauder, JM Stafford, EJ Mayer-Davis, ET Jensen, S Saydah, A Mottl, ... The Lancet Child & Adolescent Health 3 (1), 35-43, 2019 | 58 | 2019 |
| Segmental sclerosis and extracapillary hypercellularity predict diabetic ESRD AK Mottl, A Gasim, FP Schober, Y Hu, AK Dunnon, SL Hogan, ... Journal of the American Society of Nephrology 29 (2), 694-703, 2018 | 58 | 2018 |
| Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial PK Judge, N Staplin, KJ Mayne, C Wanner, JB Green, SJ Hauske, ... The Lancet Diabetes & Endocrinology 12 (1), 51-60, 2024 | 48 | 2024 |
| Moving from evidence to implementation of breakthrough therapies for diabetic kidney disease KR Tuttle, L Wong, WS Peter, G Roberts, J Rangaswami, A Mottl, ... Clinical Journal of the American Society of Nephrology 17 (7), 1092-1103, 2022 | 48 | 2022 |
| Glomerular hematuria and the utility of urine microscopy: a review MK Saha, D Massicotte-Azarniouch, ML Reynolds, AK Mottl, RJ Falk, ... American Journal of Kidney Diseases 80 (3), 383-392, 2022 | 45 | 2022 |
| KDOQI US commentary on the KDIGO 2020 clinical practice guideline for diabetes management in CKD AK Mottl, R Alicic, C Argyropoulos, FC Brosius, M Mauer, M Molitch, ... American Journal of Kidney Diseases 79 (4), 457-479, 2022 | 45 | 2022 |
| Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial N Staplin, R Haynes, PK Judge, C Wanner, JB Green, J Emberson, ... The Lancet Diabetes & Endocrinology 12 (1), 39-50, 2024 | 44 | 2024 |
